NVZMY vs CPNG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NVZMY · NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10$68.83 ▼ 4.14%
CPNG · Coupang$16.29 ▼ 0.79%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NVZMY +9.4%
- CPNG -43.7%
Head to head
| Metric | NVZMY | CPNG |
|---|---|---|
| Price | $68.83 | $16.29 |
| Change today | ▼ 4.14% | ▼ 0.79% |
| Market cap | $29.20B | $29.20B |
| Return, 3 months | +5.5% | +0.6% |
| Return, year to date | +10.1% | -30.9% |
| Return, 1 year | +9.1% | -43.6% |
| P/E (TTM) | 40.5 | – |
| P/B | 2.6 | 10.3 |
| P/E percentile vs own 5y | – | 34th |
| Dividend yield | 1.48% | – |
| Revenue growth (YoY, latest qtr) | – | +7.5% |
| Net profit growth (YoY) | – | -627.4% |
| Gross margin | – | 27.4% |
| Operating margin | – | -3.4% |
| Net margin | – | -3.8% |
| Return on equity | – | -36.0% |
| Analyst target vs. price | – | +30.9% |
| Analyst buy share | – | 67% |
| RSI (14) | 51 | 63 |
| 30-day volatility | 27.0% | 49.3% |
| Max drawdown, 1 year | -20.0% | -57.2% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NVZMY is the largest of the group by market value.
- NVZMY has returned the most over the past year.
- NVZMY has been the calmest stock over the last 30 days.